Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
10 Dec 2016 | 12:01 PM
Research Report
Weekly

Equity Research Report: Master Pick-Ranbaxy Lab

Ranbaxy has received the regulatory approval to launch India’s first NCE (New Chemical Entity), Synriam™ in seven African countries. The product has been launched in Uganda and will be made available in other countries towards end of January 2015.
09 Jan 2015 | 05:45 PM

Amid excessive volatility across the board, Ranbaxy is trading stable and formed a fresh buying pivot on the weekly chart. Traders are advised to accumulate the stock between 620-CMP (631.05) with closing below stop loss of 595 for the target of  710. 

 

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.